FDA Adverse Event Injury Summary report: N

CARPENTIER-EDWARDS PERIMOUNT RSR PERICARDIAL BIOPROSTHESIS

MDR report key: 2781311 · Received October 10, 2012

Report

Report Number
2015691-2012-18434
Event Type
Injury
Date Received
October 10, 2012
Date of Event
August 14, 2012
Report Date
September 13, 2012
Manufacturer
EDWARDS LIFESCIENCES
Product Code
DYE
PMA / PMN Number
P860057/S001
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

DEVICE NOT RETURNED. ADDITIONAL MANUFACTURER NARRATIVE: THE SUBJECT DEVICE WAS NOT EXPLANTED, THEREFORE, NO EVALUATION WILL BE PERFORMED. THE DEVICE HISTORY RECORD (DHR) REVIEW IS STILL IN PROGRESS. FOLLOW UP FOR ADDITIONAL INFORMATION IS CURRENTLY BEING MADE. A SUPPLEMENTAL MDR WILL BE SUBMITTED IN THE EVENT THAT ANY NEW INFORMATION IS RECEIVED RELATED TO THE EVENT. NO FURTHER ACTIONS ARE POSSIBLE WITH THE AVAILABLE INFORMATION.

Additional Manufacturer Narrative · 1

ADDITIONAL MANUFACTURER NARRATIVE: BASED ON THE HEALTHCARE PROVIDER'S RESPONSE, THIS PATIENT PRESENTED WITH SEVERE SYMPTOMATIC AORTIC STENOSIS AND WAS INOPERABLE FOR OPEN HEART SURGERY AND WITH ACUTE ON CHRONIC SYSTOLIC AND DIASTOLIC HEART FAILURE EXACERBATION. ULTRASOUND SHOWED EVIDENCE OF CRITICAL NARROWING OF THE PROSTHETIC AORTIC VALVE. THEREFORE, IT WAS DECIDED TO PROCEED WITH TRANSCATHETER AORTIC VALVE REPLACEMENT VIA TRANSFEMORAL APPROACH ON THE OLD VALVE. THE PROCEDURE WAS UNCOMPLICATED AND THE PATIENT REPORTEDLY DID WELL. THERE ARE SEVERAL POTENTIAL CAUSES FOR PROSTHETIC VALVE STENOSIS (E.G. CALCIFICATION, PANNUS GROWTH). UNFORTUNATELY, THE VALVE WAS NOT EXPLANTED FROM THE PATIENT; THEREFORE, THE ROOT CAUSE OF THIS EVENT COULD NOT BE INVESTIGATED. NO FURTHER ACTIONS ARE POSSIBLE WITH THE AVAILABLE INFORMATION.

Description of Event or Problem · 1

EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL "CUSTOMER COMPLAINT". THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE. IN THIS CASE, IT WAS REPORTED THAT PATIENT HAD RE-OPERATION FOR A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF APPROXIMATELY 11 YEARS AND 4 MONTHS. UNFORTUNATELY, THE REASON FOR THE RE-OPERATION HAS NOT BEEN PROVIDED. NO OTHER DETAILS REPORTED. THERE HAVE NOT BEEN ANY ALLEGATIONS OF A PRODUCT MALFUNCTION OR QUALITY DEFICIENCY. ANOTHER EDWARDS BIOPROSTHESIS VALVE WAS RE-IMPLANTED IN THE AORTIC POSITION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CARPENTIER-EDWARDS PERIMOUNT RSR PERICARDIAL BIOPROSTHESIS REPLACEMENT HEART VALVE DYE EDWARDS LIFESCIENCES 2800

Patients

Seq Age Sex Outcome Treatment
1 77 YR Hospitalization| R